Dianthus Therapeutics (DNTH) Earnings Date, Estimates & Call Transcripts → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free DNTH Stock Alerts $21.92 -0.63 (-2.79%) (As of 04:00 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 9) -$0.54 Missed By -$0.11 Consensus EPS (May. 9) -$0.43 Get Dianthus Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for DNTH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDNTH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DNTH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. Dianthus Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.79)($0.79)($0.79)Q2 20242($0.84)($0.28)($0.56)Q3 20242($0.88)($0.33)($0.61)Q4 20242($0.94)($0.57)($0.76)FY 20247($3.45)($1.97)($2.71)Q1 20251($0.65)($0.65)($0.65)Q2 20251($0.75)($0.75)($0.75)Q3 20251($0.68)($0.68)($0.68)Q4 20251($0.70)($0.70)($0.70)FY 20254($2.78)($2.78)($2.78)DNTH Earnings Date and InformationDianthus Therapeutics last issued its quarterly earnings results on May 9th, 2024. The reported ($0.54) earnings per share for the quarter, missing analysts' consensus estimates of ($0.43) by $0.11. The business earned $0.87 million during the quarter, compared to the consensus estimate of $0.48 million. Dianthus Therapeutics has generated ($5.83) earnings per share over the last year (($5.83) diluted earnings per share). Earnings for Dianthus Therapeutics are expected to decrease in the coming year, from ($2.16) to ($2.52) per share. Dianthus Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Dianthus Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/9/2024Q1 2024($0.43)($0.54)($0.11)($0.54)$0.48 million$0.87 million3/21/2024Q4 2023($1.11)($0.71)+$0.40($0.71)$0.73 million$0.46 million11/9/2023Q3 2023($0.51)($3.78)($3.27)($3.78)$0.50 million$0.92 million8/3/2023Q2 2023($3.04)($0.80)+$2.24($0.80)--11/3/2022Q3 2022($4.96)($4.32)+$0.64($4.32)--8/4/2022Q2 2022($5.92)($4.64)+$1.28($4.64)-- Get the Latest News and Ratings for DNTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2022Q1 2022($5.44)($6.24)($0.80)($6.24)--3/8/2022Q4 2021($5.12)($5.28)($0.16)($5.28)--11/4/2021Q3 2021($5.12)($4.80)+$0.32($4.80)--8/5/2021Q2 2021($5.60)($5.12)+$0.48($5.12)--5/6/2021Q1 2021($6.40)($5.76)+$0.64($5.76)--3/3/2021Q4 2020($6.88)($6.08)+$0.80($6.08)--11/5/2020Q3 2020($7.20)($5.92)+$1.28($5.92)--8/6/2020Q2 2020($8.48)($7.68)+$0.80($7.68)--5/7/2020Q1 2020($9.76)($8.16)+$1.60($8.16)--3/3/2020Q4 2019($9.28)($9.44)($0.16)($9.44)--11/13/2019Q3 2019($8.48)($8.64)($0.16)($8.64)--8/8/2019Q2 2019($7.84)($7.68)+$0.16($7.68)-- Dianthus Therapeutics Earnings - Frequently Asked Questions When is Dianthus Therapeutics's earnings date? Dianthus Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on DNTH's earnings history. Did Dianthus Therapeutics beat their earnings estimates last quarter? In the previous quarter, Dianthus Therapeutics (NASDAQ:DNTH) missed the analysts' consensus estimate of ($0.43) by $0.11 with a reported earnings per share (EPS) of ($0.54). Learn more on analysts' earnings estimate vs. DNTH's actual earnings. How much revenue does Dianthus Therapeutics generate each year? Dianthus Therapeutics (NASDAQ:DNTH) has a recorded annual revenue of $2.83 million. How much profit does Dianthus Therapeutics generate each year? Dianthus Therapeutics (NASDAQ:DNTH) has a recorded net income of -$43.56 million. DNTH has generated -$5.83 earnings per share over the last four quarters. What is Dianthus Therapeutics's EPS forecast for next year? Dianthus Therapeutics's earnings are expected to decrease from ($2.16) per share to ($2.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Cogent Biosciences Earnings Date Wave Life Sciences Earnings Date Stoke Therapeutics Earnings Date Celcuity Earnings Date Corbus Pharmaceuticals Earnings Date Shattuck Labs Earnings Date Solid Biosciences Earnings Date Acrivon Therapeutics Earnings Date Akero Therapeutics Earnings Date HilleVax Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: TD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's Earnings This page (NASDAQ:DNTH) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestWARNING about the death of the U.S. dollar…Colonial MetalsThe only AI company to buyPorter & CompanyBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dianthus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
